933693-27-7 Usage
Uses
Used in Pharmaceutical Research:
(3H-iMidazo[4,5-c]pyridin-2-yl)MethanaMine is used as a research compound for investigating the functions of the histamine H3 receptor and exploring its potential therapeutic applications in the development of new drugs.
Used in Neurological and Psychiatric Disorders:
(3H-iMidazo[4,5-c]pyridin-2-yl)MethanaMine is used as a promising candidate for the development of new drugs for the treatment of various neurological and psychiatric disorders due to its potential neuroprotective, anti-inflammatory, and cognitive-enhancing effects.
Used in Drug Development:
(3H-iMidazo[4,5-c]pyridin-2-yl)MethanaMine is used as a valuable tool for studying the histaminergic system, which aids in the development of novel therapeutic interventions for a range of conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 933693-27-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,3,6,9 and 3 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 933693-27:
(8*9)+(7*3)+(6*3)+(5*6)+(4*9)+(3*3)+(2*2)+(1*7)=197
197 % 10 = 7
So 933693-27-7 is a valid CAS Registry Number.
933693-27-7Relevant academic research and scientific papers
Dihydrothienopyrimidines for the Treatment of Inflammatory Diseases
-
Page/Page column 40-41, (2008/06/13)
The invention relates to new dihydrothienopyrimidine of formula 1, as well as pharmacologically acceptable salts, diastereomers, enantiomers, racemates, hydrates or solvates thereof, wherein X is SO or SO2, but preferably SO, and wherein R1, R2 and R3 have the meanings given in the description, and which are suitable for the treatment of respiratory or gastrointestinal complaints or diseases, inflammatory diseases of the joints, skin or eyes, diseases of the peripheral or central nervous system or cancers, as well as pharmaceutical compositions which contain these compounds.
